Anti-c-Myc Oncoprotein Antibody Clone MYC275 + MYC909

Observed Antibody Staining Data By Tissue Type:

Variations in c-Myc Oncoprotein antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in neuronal cells in the caudate nucleus, Purkinje cells in the cerebellum, squamous epithelial cells in the cervix, uterine, neuronal cells in the hippocampus, pneumocytes in lung and cells in the seminiferous ducts in testis. More moderate antibody staining intensity was present in neuronal cells in the caudate nucleus, Purkinje cells in the cerebellum, squamous epithelial cells in the cervix, uterine, neuronal cells in the hippocampus, pneumocytes in lung and cells in the seminiferous ducts in testis. Low, but measureable presence of c-Myc Oncoprotein could be seen inhematopoietic cells in the bone marrow, glandular cells in the cervix, uterine, endothelial cells in the colon, glandular cells in the colon, endometrium and fallopian tube, glial cells in the hippocampus, bile duct cells in the liver, germinal center cells in the lymph node, ovarian stroma cells in the ovary, glandular cells in the parathyroid gland, trophoblastic cells in the placenta, glandular cells in the salivary gland, fibroblasts in skin, Langerhans in skin, melanocytes in skin, smooth muscle cells in the smooth muscle, adipocytes in mesenchymal tissue, fibroblasts in mesenchymal tissue, peripheral nerve in mesenchymal tissue, cells in the white pulp in spleen and glandular cells in the thyroid gland. We were unable to detect c-Myc Oncoprotein in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.